Inbody Coltd Stock Current Valuation
| 041830 Stock | KRW 24,100 1,600 6.23% |
Valuation analysis of InBody CoLtd helps investors to measure InBody CoLtd's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that InBody CoLtd's price fluctuation is very steady at this time. Calculation of the real value of InBody CoLtd is based on 3 months time horizon. Increasing InBody CoLtd's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since InBody CoLtd is currently traded on the exchange, buyers and sellers on that exchange determine the market value of InBody Stock. However, InBody CoLtd's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 24100.0 | Real 22301.25 | Hype 24100.0 | Naive 23755.67 |
The real value of InBody Stock, also known as its intrinsic value, is the underlying worth of InBody CoLtd Company, which is reflected in its stock price. It is based on InBody CoLtd's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of InBody CoLtd's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of InBody CoLtd helps investors to forecast how InBody stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of InBody CoLtd more accurately as focusing exclusively on InBody CoLtd's fundamentals will not take into account other important factors: InBody CoLtd Company Current Valuation Analysis
InBody CoLtd's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current InBody CoLtd Current Valuation | 331.29 B |
Most of InBody CoLtd's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InBody CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, InBody CoLtd has a Current Valuation of 331.29 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.
InBody Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InBody CoLtd's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InBody CoLtd could also be used in its relative valuation, which is a method of valuing InBody CoLtd by comparing valuation metrics of similar companies.InBody CoLtd is currently under evaluation in current valuation category among its peers.
InBody Fundamentals
| Return On Equity | 18.84 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 331.29 B | |||
| Shares Outstanding | 13.48 M | |||
| Shares Owned By Insiders | 28.69 % | |||
| Shares Owned By Institutions | 19.22 % | |||
| Price To Earning | 30.89 X | |||
| Price To Sales | 2.02 X | |||
| Revenue | 137.84 B | |||
| Gross Profit | 77.06 B | |||
| EBITDA | 37.57 B | |||
| Net Income | 33.98 B | |||
| Cash And Equivalents | 18.56 B | |||
| Total Debt | 1.83 B | |||
| Current Ratio | 4.60 X | |||
| Cash Flow From Operations | 30.35 B | |||
| Target Price | 33000.0 | |||
| Number Of Employees | 222 | |||
| Beta | 1.01 | |||
| Market Capitalization | 326.28 B | |||
| Total Asset | 203.76 B | |||
| Retained Earnings | 73.14 B | |||
| Working Capital | 53.19 B | |||
| Current Asset | 64.45 B | |||
| Current Liabilities | 11.26 B | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 203.76 B |
About InBody CoLtd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InBody CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InBody CoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InBody CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with InBody CoLtd
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InBody CoLtd position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InBody CoLtd will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to InBody CoLtd could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InBody CoLtd when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InBody CoLtd - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InBody CoLtd to buy it.
The correlation of InBody CoLtd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InBody CoLtd moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InBody CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InBody CoLtd can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in InBody Stock
InBody CoLtd financial ratios help investors to determine whether InBody Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in InBody with respect to the benefits of owning InBody CoLtd security.